The Department of Pharmaceuticals has constituted a committee to examine the existing regulatory framework governing pharmaceutical marketing practices and recommend measures to curb unethical activities in the sector, an official statement said on Friday.
The committee will be chaired by NITI Aayog Member M Srinivas. Former Union Health Secretary Preeti Sudan and Medanta CMD Naresh Trehan will serve as its members.
According to the statement by Ministry of Chemicals and Fertilisers, the panel will examine the existing -egulatory set-up and suggest measures to strengthen oversight, monitoring, and enforcement mechanisms co check unethical pharmaceutical marketing practices.
The panel will have to submit its recommendations within two months from the date of its first meeting, Following a consultative process.
The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) was first introduced in 2015 as a voluntary, industry-led self-regulatory mechanism to promote ethical marketing and govern interactions Detween pharma firms and healthcare professionals. The department later introduced the UCPMP 2024, which superseded the 2015 code with a strengthened implementation framework and is currently in Operation.
Source: Moneycontrol
